cynn
cynn
暂无个人介绍
IP属地:未知
309关注
9粉丝
0主题
0勋章
avatarcynn
2021-12-10
Ok
TSMC’s November sales were 148.27 billion Taiwan dollars, an increase of 18.7% year-on-year.<blockquote>台积电11月销售额为1482.7亿元新台币,同比增长18.7%。</blockquote>
avatarcynn
2021-12-06
Ok
The Housing Boom Could Last for a Decade. Buy These Stocks.<blockquote>房地产繁荣可能会持续十年。购买这些股票。</blockquote>
avatarcynn
2021-11-10
Great
Tencent revenues increased by 13% to RMB142.4 billion for the third quarter of 2021 on a year-on-year basis.<blockquote>2021年第三季度腾讯控股收入同比增长13%至人民币1,424亿元。</blockquote>
avatarcynn
2021-11-10
Ok
抱歉,原内容已删除
avatarcynn
2021-10-23
avatarcynn
2021-10-19
Great news
Alibaba rose nearly 2% in premarket trading as it unveils one of China’s most advanced chips<blockquote>阿里巴巴-SW在盘前交易中上涨近2%,推出中国最先进的芯片之一</blockquote>
avatarcynn
2021-10-11
$Alibaba(BABA)$finally. Up and up
avatarcynn
2021-10-01
👍 
European stock markets tumble amid fears of slowing economic growth<blockquote>由于担心经济增长放缓,欧洲股市暴跌</blockquote>
avatarcynn
2021-09-24
$Alibaba(BABA)$[流泪] [流泪] 
avatarcynn
2021-09-24
avatarcynn
2021-09-23
Good news
Fed signals possibility of 6 to 7 rate hikes through 2024 as taper talks advance<blockquote>随着缩减规模谈判的推进,美联储暗示到 2024 年可能加息 6 至 7 次</blockquote>
avatarcynn
2021-09-18
True
抱歉,原内容已删除
avatarcynn
2021-09-09
Time to go in
Sea Aims to Raise $6.3 Billion in 2021’s Biggest Equity Deal<blockquote>Sea 计划在 2021 年最大的股票交易中筹集 63 亿美元</blockquote>
avatarcynn
2021-09-07
Sea price keep going up.  
Sea reached record high in pre-market trading<blockquote>Sea盘前交易创历史新高</blockquote>
avatarcynn
2021-09-05
Like
Beat the market with this quant system that’s very bullish on stocks at record highs<blockquote>利用这个量化系统战胜市场,该系统非常看好创纪录高点的股票</blockquote>
avatarcynn
2021-09-05
Ok
抱歉,原内容已删除
avatarcynn
2021-09-04
True
2 Good Reasons the Stock Market Isn’t Ready to Blow Up Yet<blockquote>股市尚未准备好爆炸的 2 个充分理由</blockquote>
avatarcynn
2021-09-03
Ok
Why Moderna Trounced the Market on Thursday<blockquote>为什么 Moderna 周四击败市场</blockquote>
avatarcynn
2021-08-31
Great
Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis<blockquote>辉瑞公司的3期Jade Dare试验比较了Abrocitinib和Dupilumab治疗中度至重度特应性皮炎的疗效,取得了积极的顶线结果</blockquote>
avatarcynn
2021-08-25
Ok
抱歉,原内容已删除

去老虎APP查看更多动态